Gilead Sciences is trading at ARS 73,375.00, up 4.60%, with biotech-sector strength.
- The biotech index rose about 2.1% during the November 4 session, and Gilead gained alongside the rally.
- On November 4, Gilead announced 23 planned presentations at Decemberβs ASH meeting, including new pipeline and follow-up data. Available evidence does not establish the announcement as the direct cause of the share move.